Sustained Release Excipients Market Size, Share Report, 2031Posted by pooja on August 4th, 2022  The demand within the global sustained release excipients market has been rising on account of key improvements in the pharmaceutical industry. Sustained dosing of drugs holds immense significance for a range of industries, and hence, the use of sustained release excipients has become more pronounced in recent times. Excipients for modified release help in releasing drugs at a slow pace over an extended time period, and this helps in avoiding dose-dumping. The global sustained release excipients market is projected to keep expanding over the forthcoming years. This projection is based on the expansive developments that have offset in the pharmaceutical industry over the past decade. The ability of sustained drug release to relieve patients of pain has created tremendous demand within the global market for sustained release excipients in recent times. Furthermore, the advantages served by sustained drug release over conventional drugs are also expected to give an impetus to the growth of the global sustained release excipients market. Some of the key players in the global sustained release excipients market are Depomed, Inc.; Capsugel; Aradigm Corporation; Corium International, Inc.; and Orbis Biosciences, Inc. Get Sample Copy Of This Report: https://www.tmrresearch.com/sample/sample?flag=B&rep_id=4368
About TMR Research Contact: Like it? Share it! More by this author |